Skip to content

Ibogaine: all studies

Page 53 of 62: studies 521 to 530 of 613, newest first. Back to the ibogaine overview

Research

Central nervous system activity of a Tabernaemontana arborea alkaloid extract involves serotonergic and opioidergic neurotransmission in murine models.

Fitoterapia September 1, 2023 M E González-trujano, N Páez-martínez, Felix Krengel et al. 4 citations

Tabernaemontana arborea (Apocynaceae) is a Mexican tree species known to contain ibogan type alkaloids. This study aimed at determining central nervous system-related activities of an alkaloid extract obtained from the root bark of T. arborea. A gas chromatography-mass spectrometry (GC-MS) analysis was performed to describe the alkaloid profile of the extract. A wide dosing range (0.1 to 56.2...

DOI: 10.1016/j.fitote.2023.105602 (opens in new tab) Full text (opens in new tab) Antidepressant-like activity Antinociceptive Memory impairment Tabernaemontana phytochemistry: tabernaemontana +13

Natural psychedelics in the treatment of depression; a review focusing on neurotransmitters.

Fitoterapia September 1, 2023 Samane Jahanabadi, Shayan Amiri, Mehdi Karkeh-Abadi et al. 14 citations

Natural psychedelic compounds are emerging as potential novel therapeutics in psychiatry. This review will discuss how natural psychedelics exert their neurobiological therapeutic effects, and how different neurotransmission systems mediate the effects of these compounds. Further, current therapeutic strategies for depression, and novel mechanism of action of natural psychedelics in the...

Neuroimaging in psychedelic drug development: past, present, and future.

Molecular Psychiatry September 1, 2023 Matthew B. Wall, Rebecca Harding, Rayyan Zafar et al. 39 citations

Psychedelic therapy (PT) is an emerging paradigm with great transdiagnostic potential for treating psychiatric disorders, including depression, addiction, post-traumatic stress disorder, and potentially others. 'Classic' serotonergic psychedelics, such as psilocybin and lysergic acid diethylamide (LSD), which have a key locus of action at the 5-HT2A receptor, form the main focus of this...

DOI: 10.1038/s41380-023-02271-0 (opens in new tab) Full text (opens in new tab) Psychedelics Mental health Brain imaging Pharmacology

Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders

Journal of Psychoactive Drugs August 24, 2023 Stanley Wong, An Yi Yu, Nicholas Fabiano et al. 11 citations

There has been a resurgence of interest in the use of psychedelic therapies for several mental and substance use disorders. Psilocybin, a "classic" serotonergic psychedelic, has emerged as one of the primary compounds of interest in clinical research. While research on psilocybin's potential mental health benefits has grown, data on the safety and efficacy of other serotonergic psychedelics...

Hallucinogenic potential: a review of psychoplastogens for the treatment of opioid use disorder

Frontiers in Pharmacology August 22, 2023 Mary G. Hornick, Ashley Stefanski 9 citations

The United States is entering its fourth decade of the opioid epidemic with no clear end in sight. At the center of the epidemic is an increase in opioid use disorder (OUD), a complex condition encompassing physical addiction, psychological comorbidities, and socioeconomic and legal travails associated with the misuse and abuse of opioids. Existing behavioral and medication-assisted therapies...

Food of the Gods?

July 7, 2023 Neil Carrier, Lisa L. Gezon

This chapter focuses on drugs in spiritual and religions contexts, considering their role in altered states of consciousness, divination and healing. The first part of the chapter presents the sub-discipline of ethnobotany and its contribution to anthropological ideas about hallucinogenic plant substances and their wider connection of drugs to shamanism and the spirit world. It also discusses...

Experts Offer Tips on Talking With Patients About Psychedelics

Psychiatric News June 28, 2023 Terri D’arrigo

Back to table of contents Previous article Next article Annual MeetingFull AccessExperts Offer Tips on Talking With Patients About PsychedelicsTerri D’ArrigoTerri D’ArrigoSearch for more papers by this authorPublished Online:28 Jun 2023https://doi.org/10.1176/appi.pn.2023.07.7.51AbstractPsychedelics differ from one another in their mechanism of action and potential effects on the body and mind....

DOI: 10.1176/appi.pn.2023.07.7.51 (opens in new tab) MDMA Counterculture Psychoanalysis Psychotherapist +2

Tabernanthalog Reduces Motivation for Heroin and Alcohol in a Polydrug Use Model.

Psychedelic Medicine June 1, 2023 Jasper A Heinsbroek, Giuseppe Giannotti, Joel Bonilla et al. 26 citations

The potential use of psychedelic drugs as therapeutics for neuropsychiatric disorders has been limited by their hallucinogenic properties. To overcome this limitation, we developed and characterized tabernanthalog (TBG), a novel analogue of the indole alkaloids ibogaine and 5-methoxy-N,N-dimethyltryptamine with reduced cardiac arrhythmogenic risk and a lack of classical psychedelic...

Structure-based discovery of conformationally selective inhibitors of the serotonin transporter.

Cell May 11, 2023 Isha Singh, Anubha Seth, Christian B. Billesbølle et al. 97 citations

The serotonin transporter (SERT) removes synaptic serotonin and is the target of anti-depressant drugs. SERT adopts three conformations: outward-open, occluded, and inward-open. All known inhibitors target the outward-open state except ibogaine, which has unusual anti-depressant and substance-withdrawal effects, and stabilizes the inward-open conformation. Unfortunately, ibogaine's promiscuity...

Editorial: Pharmacology of new psychoactive substances

Frontiers in Pharmacology May 9, 2023 Kabirullah Lutfy, Robert N. Pechnick, Nissar A. Darmani 1 citation

Pharmacology of new psychoactive substancesSeveral classes of novel psychoactive substances have been introduced in illicit markets throughout the world and more are being developed.They present major law enforcement challenges and global public health threats.However, there is limited information on their harmful effects on the central nervous, cardiovascular, respiratory, and gastrointestinal...